Expression of Bone Morphogenetic Protein and Its Receptor in Fibroblastic Osteosarcoma and Malignant Fibrous Histiocytoma and Its Significance in Differential Diagnosis

黄瑾,张惠箴,郑莉,陈杰,刘亮,蒋智铭
DOI: https://doi.org/10.3969/j.issn.1001-7399.2010.03.020
2010-01-01
Experimental Pathology
Abstract:Purpose To investigate the expression of bone morphogenetic protein and its receptor in fibroblastic osteosarcoma and malignant fibrous histiocytoma(MFH) and its significance for their differential diagnosis.Methods Ten cases of fibroblastic type osteosarcoma and 10 cases of MFH were studied by light microscopy and immunohistochemistry.Results The mean age of 10 cases of fibroblastic osteosarcoma was 27.7 and they all located in the metaphysis of long tubular bones.BMP2/4 and BMPRII were simultaneously stained positively in 8 cases.However,10 cases of MFH had a mean age of 48.5 years.7 of 10 cases occurred in the metaphysis of long tubular bones,two in the diaphysis of long tubular bones and one in the soft tissues of thigh.The tumor cells stained positively for BMP2/4 in 8 cases,but stained negatively for BMPRII in all cases.Under light microscope,the main component of fibroblastic osteosarcoma and MFH were high-grade spindle cell sarcoma,and their key difference was the formation of osseous matrix in osteosarcoma but absent in MFH.Conclusions BMP2/4 and BMPRII are simultaneously detected in fibroblastic osteosarcoma,but MFH expresses BMP2/4 but not BMPRII,which may explain the reason why MFH tumor cells do not ossify.At the same time,this expression difference provides a useful indicator for their differential diagnosis.
What problem does this paper attempt to address?